Dr. Thibault is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9607 Singleton Dr
Bethesda, MD 20817Phone+1 301-564-5757
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1991 - 1994
- McGill University Faculty of MedicineClass of 1986
Certifications & Licensure
- VA State Medical License 1995 - 2014
Publications & Presentations
PubMed
- 124 citationsPhase II Study of R115777, a Farnesyl Transferase Inhibitor, in Myelodysplastic SyndromeRazelle Kurzrock, M. Albitar, Jorge E. Cortes, Elihu H. Estey, Stefan Faderl
Journal of Clinical Oncology. 2004-04-01 - 98 citationsLipid Metabolism as a Target for Brain Cancer Therapy: Synergistic Activity of Lovastatin and Sodium Phenylacetate Against Human Glioma CellsPremakala Prasanna, Alain Thibault, Lei Liu, Dvorit Samid
Journal of Neurochemistry. 2002-11-23 - 360 citationsClinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory corre...Judith E. Karp, Jeffrey E. Lancet, Scott H. Kaufmann, David W. End, John J. Wright
Blood. 2001-06-01
Press Mentions
- ITeos Therapeutics Announces Appointment of Dr. Alain Thibault as Chief Medical OfficerJune 21st, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: